Results 151 to 160 of about 133,164 (249)

Risk Assessment of an Illegal Laboratory in Reedley, California, Using Geospatial Analysis of Open‐Source Epidemic Intelligence Data

Risk Analysis, Volume 46, Issue 11, November 2026.
ABSTRACT An illegal laboratory discovered in Reedley, California, in December 2022 was in a warehouse, operating without a license, handling about a thousand transgenic mice, chemicals, and possibly over 20 pathogens, including vials labeled Ebola, which were never tested but destroyed.
Atalay Goshu Muluneh, Rebecca Dawson, Jared Edgeworth, Natalie L. Cain, Ashley Quigly, Aye Moa, Samsung Lim, Chandini Raina MacIntyre   +7 more
wiley   +1 more source

From Dysbiosis to Disease: How Vaginal Microbiota Shape Group B Streptococcus Pathogenesis

ChemBioChem, Volume 27, Issue 20, 28 October 2026.
Lactobacillus crispatus plays a critical role in the vaginal microbiome. Limiting glucose shifts metabolism toward HMO consumption and amino acid metabolism. These actions enable alkali production and competition. Homeostasis, characterized by dense Lactobacilli colonization and suppression of pathogens, provides resistance to dysbiosis.
Julie A. Talbert, Steven D. Townsend
wiley   +1 more source

Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

Emerging Infectious Diseases, 2022
Ian G. Barr, Thomas C. Williams, Vahid Salimi, Ursula J. Buchholz   +3 more
doaj   +1 more source

Past and Present Vaccinations in Sweden

Acta Paediatrica, Volume 115, Issue 11, Page 2505-2510, November 2026.
Sven Arne Silfverdal
wiley   +1 more source

Validation of Small‐Molecule Entry Inhibitors Targeting the Respiratory Syncytial Virus

ChemMedChem, Volume 21, Issue 20, 28 October 2026.
Respiratory syncytial virus (RSV) remains a major cause of severe respiratory disease, while effective treatments for acute infection are still limited. We screened small‐molecule RSV entry inhibitors and investigated promising hits through resynthesis and antiviral testing.
Christina Karhan, Svenja M. Sake, Melanie Urbanek‐Quaing, Diletta Bergamo, Jessica Rückert, Jiabin Huang, Christina Grethe, Antonia P. Gunesch, Anne Kühnel, Birthe Reinecke, Nicole Fischer, Thomas F. Schulz, Thomas Pietschmann, Anna K. H. Hirsch   +13 more
wiley   +1 more source

The molecular epidemiology of human respiratory syncytial virus in a tertiary paediatric hospital between 2020 and 2024. [PDF]

J Coll Med S Afr
Maseko MJ, Joseph R, Korsman SNJ, Valley-Omar Z, Hsiao NY.   +4 more
europepmc   +1 more source

mRNA cap formation by the human respiratory syncytial virus large protein. [PDF]

Nucleic Acids Res
Watkins DE, Carpenter K, Yu T, Ogino M, Ogino T.   +4 more
europepmc   +1 more source

Potential effects of genetic variations in fusion protein on the virulence of human respiratory syncytial virus. [PDF]

Front Immunol
Song J, Wang N, Zhu Z, Mao N, Li H, Song J, Cao L, Xia B, Liao M, Zhu W, Zhang Y.   +10 more
europepmc   +1 more source

Innate airway responses shape permissiveness to human respiratory syncytial virus. [PDF]

Virus Res
van Dijk LLA, Rijsbergen LC, Havelaar AC, den Hartog Y, Koutstaal RW, Groen K, de Vries RD, de Swart RL.   +7 more
europepmc   +1 more source

Comparative analysis of ARIMA and Holt-Winter's additive models for describing human respiratory syncytial virus activity in Yaoundé, Cameroon. [PDF]

Int J Public Health
Moumbeket-Yifomnjou MH, Monamele CG, Tsafack DT, Njankouo MR, Mounchili-Njifon A, Tagnouokam-Ngoupo PA, Modiyinji AF, Onana B, Njouom R.   +8 more
europepmc   +1 more source